National Health Investors, Inc. (NYSE:NHI – Get Free Report) CEO D. Eric Mendelsohn bought 1,500 shares of the stock in a transaction on Friday, June 5th. The shares were acquired at an average cost of $68.84 per share, with a total value of $103,260.00. Following the acquisition, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.
National Health Investors Trading Up 2.8%
Shares of NYSE NHI traded up $1.94 during midday trading on Friday, reaching $70.26. 70,008 shares of the stock were exchanged, compared to its average volume of 338,838. The business has a 50-day simple moving average of $78.59 and a two-hundred day simple moving average of $80.38. The company has a market capitalization of $3.41 billion, a price-to-earnings ratio of 22.66, a P/E/G ratio of 3.63 and a beta of 0.52. National Health Investors, Inc. has a 12 month low of $67.94 and a 12 month high of $91.38. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20.
National Health Investors (NYSE:NHI – Get Free Report) last announced its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). The firm had revenue of $115.13 million for the quarter, compared to the consensus estimate of $70.22 million. National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The company’s revenue for the quarter was up 28.9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.15 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, equities research analysts expect that National Health Investors, Inc. will post 5.07 EPS for the current year.
National Health Investors Dividend Announcement
Analyst Ratings Changes
NHI has been the topic of a number of recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a research report on Wednesday, April 22nd. Wells Fargo & Company reduced their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research report on Monday. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research report on Friday, March 27th. Finally, Truist Financial reduced their price target on shares of National Health Investors from $92.00 to $89.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $86.67.
View Our Latest Stock Report on National Health Investors
Institutional Investors Weigh In On National Health Investors
Institutional investors have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC bought a new stake in National Health Investors in the 4th quarter valued at $27,000. EverSource Wealth Advisors LLC lifted its position in National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in National Health Investors in the 4th quarter valued at $33,000. GAMMA Investing LLC lifted its position in National Health Investors by 41.8% in the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 136 shares in the last quarter. Finally, Key Capital Management INC bought a new stake in National Health Investors in the 4th quarter valued at $47,000. 62.51% of the stock is owned by institutional investors.
National Health Investors Company Profile
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Read More
- Five stocks we like better than National Health Investors
- NVIDIA’s New Power Play: Why Fluence Is Surging
- Broadcom’s Whiplash: Shares Tank After Pre-Earnings Surge
- Five Below Down 12% Post Earnings—Is the Selloff Overdone?
- The Market Has Ollie’s Bargain Outlet Completely Wrong
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
